IDEXX Laboratories has considerably outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.
While Intuitive Surgical has underperformed the broader market this past year, analysts maintain a fairly bullish stance on its future prospects.
Solventum has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.
While Align Technology has considerably underperformed its industry peers recently, analysts remain moderately optimistic about the stock’s prospects.
IDEXX Laboratories' stock has significantly outperformed the broader market over the past year, but analysts are cautiously bullish about its growth potential.
Cooper Companies has been underperforming the broader market over the past year, but analysts still seem to be moderately optimistic about the stock's prospects.
Intuitive Surgical has fallen behind the broader market over the past year, though analysts still express a guardedly optimistic stance on the company’s prospects.
While Medtronic has struggled to keep up with the broader market over the past year, analysts remain fairly upbeat on its future growth prospects.
Solventum has outperformed relative to its healthcare equipment peers over the past year, but Wall Street analysts maintain a skeptical view on the stock’s outlook.